| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8650985 | American Heart Journal | 2018 | 20 Pages |
Abstract
Patients with HFrEF taking carvedilol had improved survival as compared to metoprolol succinate. The data supports the need for furthering testing to determine optimal choice of beta blockers in patients with heart failure with reduced ejection fraction.
Keywords
ACCAFIBAHAICD-9HbA1cImplantable cardioverter defibrillatorAmerican Heart AssociationPeripheral artery diseaseCOPDChronic obstructive pulmonary diseasechronic kidney diseaseICDInternational Classification of Diseases, Ninth RevisionAtrial fibrillationheart failureCKDhazard ratioglycosylated hemoglobin A1cPADAmerican College of Cardiology
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tarek MD, MS, Samer MD, Srikant PhD, Kahee MD, MPH, Stephen MD, Masoor MD,